Table 1.
Overview of Hematologic Diagnoses, Treatment Regimens, Remission Status, Hospital Stays, and Severity of Coronavirus Disease-19 Infection in the Sample
| Diagnosis | No. of Patients | Chemotherapy ± Immunotherapy/Oral Inhibitorsand Targeted Therapy/Other Regimensand Combinations/No Treatment | Complete Remission (%) | Inpatient Treatment (%) | Severe to Critical/Asymptomatic to Moderate Course of COVID-19/Not Detected |
|---|---|---|---|---|---|
| Lymphoproliferative disorders | 65 | 27 / 17 / 3 / 18 | 12 (18.5) | 51 (78.5) | 19 / 38 / 8 |
| Chronic lymphocytic leukemia | 20 | 4 / 8 / 0 / 8 | 4 | 17 | 8 / 8 / 4 |
| Multiple myeloma | 11 | 1 / 7 / 3 / 0 | 4 | 5 | 3 / 7 / 1 |
| Diffuse large B-cell lymphoma | 8 | 7 / 0 / 0 / 1 | 0 | 8 | 1 / 5 / 2 |
| Follicular lymphoma | 6 | 5 / 0 / 0 / 1 | 1 | 4 | 2 / 4 / 0 |
| Hodgkin lymphoma | 3 | 2 / 0 / 0 / 1 | 0 | 2 | 1 / 2 / 0 |
| B-cell non-Hodgkin lymphoma, NOS | 3 | 2 / 0 / 0 / 1 | 0 | 3 | 1 / 2 / 0 |
| Mantle cell lymphoma | 2 | 1 / 0 / 0 / 1 | 1 | 2 | 0 / 2 / 0 |
| T-cell non-Hodgkin lymphoma | 2 | 1 / 0 / 0 / 1 | 0 | 2 | 0 / 2 / 0 |
| Burkitt lymphoma | 2 | 2 / 0 / 0 / 0 | 0 | 2 | 1 / 1 / 0 |
| Hairy cell leukemia | 2 | 0 / 0 / 0 / 2 | 0 | 1 | 0 / 1 / 1 |
| Acute lymphoblastic leukemia | 2 | 1 / 1 / 0 / 0 | 2 | 1 | 0 / 2 / 0 |
| Marginal zone lymphoma | 1 | 0 / 0 / 0 / 1 | 0 | 1 | 0 / 1 / 0 |
| Waldenstrom macroglobulinemia | 1 | 1 / 0 / 0 / 0 | 0 | 1 | 1 / 0 / 0 |
| CLL + MM | 1 | 0 / 1 / 0 / 0 | 0 | 1 | 0 / 1 / 0 |
| CLL + WM | 1 | 0 / 0 / 0 / 1 | 0 | 1 | 1 / 0 / 0 |
| Myeloproliferative disorders | 29 | 7 / 7 / 13 / 2 | 14 (48.3) | 18 (62.1) | 8 / 19 / 2 |
| Acute myeloid leukemia | 12 | 7 / 0 / 4 / 1 | 7 | 11 | 6 / 6 / 0 |
| Chronic myeloid leukemia | 7 | 0 / 7 / 0 / 0 | 7 | 1 | 0 / 6 / 1 |
| Myelodysplastic syndrome | 4 | 0 / 0 / 3 / 1 | 0 | 3 | 1 / 3 / 0 |
| Polycythemia vera | 2 | 0 / 0 / 2 / 0 | 0 | 1 | 1 / 1 / 0 |
| Primary thrombocythemia | 2 | 0 / 0 / 2 / 0 | 0 | 1 | 0 / 1 / 1 |
| Primary myelofibrosis | 1 | 0 / 0 / 1 / 0 | 0 | 0 | 0 / 1 / 0 |
| Chronic myelomonocytic leukemia | 1 | 0 / 0 / 1 / 0 | 0 | 1 | 0 / 1 / 0 |
| Bone marrow failure syndromes | 2 | 0 / 0 / 1 / 1 | 1 (50.0) | 0 (0) | 0 / 2 / 0 |
| Aplastic anemia | 1 | 0 / 0 / 0 / 1 | 0 | 0 | 0 / 1 / 0 |
| Paroxysmal nocturnal hemoglobinuria | 1 | 0 / 0 / 1 / 0 | 1 | 0 | 0 / 1 / 0 |
Abbreviations: CLL = chronic lymphocytic leukemia; MM = multiple myeloma; WM = Waldenstrom macroglobulinemia; NOS = not otherwise specified.